Copyright: ©Author(s) 2026.
World J Diabetes. Jun 15, 2026; 17(6): 118650
Published online Jun 15, 2026. doi: 10.4239/wjd.118650
Published online Jun 15, 2026. doi: 10.4239/wjd.118650
Figure 5 Effect of Tangwang formula on retinal injury in diabetic retinopathy mice (n = 10) and mouse retinal endothelial cells (n = 3).
A: The levels of tissue factors in mouse serum; B: The protein expression of tissue factors in the retina; C: Immunofluorescence staining of vascular endothelial growth factor and zonula occludens-1 in the retina of diabetic retinopathy mice; D: Immunofluorescence staining of vascular endothelial growth factor and zonula occludens-1 in mouse retinal endothelial cells at 48 hours. bP < 0.01 vs control group, cP < 0.05 vs model group, and dP < 0.01 vs model group. CaD: Calcium dobesilate; HCY: Homocysteine; RAGE: Receptor advanced glycation end products; TWF: Tangwang formula; TWF-L: 30 mmol/L glucose with 25 μg/mL Tangwang formula; TWF-M: 30 mmol/L glucose with 50 μg/mL Tangwang formula; TWF-H: 30 mmol/L glucose with 100 μg/mL Tangwang formula; VEGF: Vascular endothelial growth factor; ZO-1: Zonula occludens-1.
- Citation: Zhang H, Xing JX, Yin YF, Li J, Jing CX, Liu SY, Yin JZ, Gao X, Liang ZG, Yuan TY, Su H, Li YQ, Wang ZY, Dong HS, Zhao DQ, Ying DS, Zhou ZW, Huang QX. Tangwang formula ameliorates diabetic retinopathy by inhibiting cell apoptosis and regulating the intestinal microbiota and metabolic profiles. World J Diabetes 2026; 17(6): 118650
- URL: https://www.wjgnet.com/1948-9358/full/v17/i6/118650.htm
- DOI: https://dx.doi.org/10.4239/wjd.118650